Accelerate Gene Editing Discoveries
with Confidence
Streamline gene editing validation with our single-mismatch genotyping technology
The era of Cell & Gene Therapy is here! CRISPR-Cas and additional groundbreaking gene-editing technologies are revolutionizing the field, with more therapies steadily advancing to clinical use. At Countagen, our mission is to accelerate the journey from discovery to practical use for these cutting-edge treatments.
Our flagship product, GeneAbacus, enables rapid and streamlined genotyping for gene editing validation. Designed for in-house use with standard laboratory equipment, it delivers precise and actionable gene editing efficiency analysis within just five hours, accelerating the pace of discovery and development of Cell & Gene Therapies.
Ensuring Responsible Gene Editing
The rapid pace of gene editing breakthroughs requires a parallel focus on responsible application. Precise genotyping for gene editing validation is critical for several reasons:
- Safety: Ensuring edits occur at the intended location and do not introduce unintended changes is crucial for patient safety.
- Efficacy: Understanding the editing efficiency allows researchers to optimize protocols and maximize therapeutic effects.
- Reproducibility: Reliable analysis methods are essential for replicating results and advancing research.
Current Validation Methods: Bottlenecks in Progress
Traditional genotyping methods often present significant challenges:
- Fragmented and Outsourced workflows: Dependence on weeks of waiting queue for external services can significantly delay validation of single gene-editing targets.
- Target-by-target optimization: Every new target requires dedicated optimization efforts that consume time & resources and also results in lack of standardization.
- Limited precision: Current methods for rapid genotyping have limited single-nucleotide precision, making it difficult to accurately assess gene editing outcomes.
These limitations hinder the progress of gene editing innovation and ultimately slow down the development of potentially life-saving therapies.
Streamlining Discoveries with GeneAbacus
Countagen is invested in advancing gene editing innovation through a proprietary genotyping technology for gene-editing validation. Our flagship product, GeneAbacus, addresses the limitations of traditional methods by offering:
- Rapid Turnaround Time: Obtain accurate results in-house within a single day, significantly accelerating timelines.
- Single-Nucleotide Precision: GeneAbacus utilizes padlock probes and rolling circle amplification to achieve single-nucleotide precision, providing the confidence you need in your validation results.
- Simplified Workflow: Seamlessly integrate GeneAbacus into your existing laboratory workflow. The assay requires no optimization and is compatible with standard lab equipment.
Our Genotyping Technology: A Catalyst for Progress
By offering a fast, reliable, and user-friendly genotyping solution for gene editing validation, GeneAbacus is paving the way for advancements in Cell & Gene Therapy research and development.
- Accelerate the development of new treatments: Faster, reliable genotyping enables efficient gene-editing optimization and accelerates progress toward clinical applications.
- Enhance the safety and efficacy of therapies: Precise analysis ensures gene edits occur at the intended location and with optimal efficiency, contributing to safer and more effective treatments.
- Drive responsible gene editing practices: Reliable data informs decision-making and promotes responsible application of this gene-editing technologies.
Join Us in Shaping the Future of Healthcare
Countagen is dedicated to working alongside customers to unlock the full potential of gene editing. We are committed to accelerating progress toward cell and gene therapy advancements.
Check out our FAQ to learn more about how we can support your needs.
Subscribe to Our Newsletter